MEDIS HOLDING B.V.

Medis Medical Imaging Systems is a Netherlands-based software company founded in 1989 as a spin-off from Leiden University Medical Centre. Specializing in vendor-independent, AI-powered cardiovascular image analysis software, Medis develops solutions for quantitative analysis across multiple imaging modalities including X-ray, CT, MRI, ultrasound, and intravascular imaging (IVUS/OCT). The company's flagship products include Medis QFR® (coronary physiology analysis via deep learning), Medis Suite MR (cardiac MRI post-processing), Medis Suite CT (cardiovascular CT quantification), Medis Suite XA (coronary and ventricular X-ray analysis), Medis Suite Ultrasound (cardiac deformation analysis), and Intravascular (IVUS/OCT post-processing). With ~126 employees globally and operations across 27+ countries, Medis serves hospitals, imaging centers, and research institutions. The company holds multiple patents and certifications; Medis QFR® has Class I recommendations in the 2024 ESC Guidelines for chronic coronary syndrome management. Medis emphasizes scientific rigor, clinical workflow efficiency, and user-oriented design in supporting cardiologists, radiologists, and researchers.